Archives: News
-
News
Toward European roadmap for the evaluation of digital medical devices
Learn moreThe World Health Organisation currently lists more than 2 million devices with a medical purpose. These innovative health technologies are transforming the medical landscape. They have the potential to improve healthcare for patients, providers and payers but are also disrupting the European regulatory landscape. Although the integration of these technologies is a strategic priority for…
-
News
FNR awards 2022 – LCSB researchers in the spotlight
Learn moreOn 20 October, the Luxembourg National Research Fund (FNR) presented the FNR Awards 2022 to reward exceptional contributions to science and science communication in Luxembourg. During the ceremony, Prof. Rejko Krüger, head of the Translational Neuroscience group at the Luxembourg Centre for Systems Biomedicine (LCSB) and director of Transversal Translational Medicine at the Luxembourg Institute of Health…
-
News
Research paper highlighted at the Movement Disorders Society Congress
Learn moreA paper published by the Molecular and Functional Neurobiology group at the LCSB was mentioned during the Movement Disorders Society meeting organised in Madrid in September 2022. The study, focusing on the role of different cell types present in the human midbrain in Parkinson’s disease, was highlighted during the plenary session in a list of interesting fundamental research published this…
-
News
Multiple Types of Long COVID Identified for the First Time
Learn moreAll-Luxembourg study finds that Long COVID is not just a single disease but can take a variety of forms with different symptoms and potential treatments.
-
News
The Expobiome Map – Exploring the role of microbiome-derived molecules
Learn moreThe human microbiome, the collection of microorganisms that live in and on our body, is intricately connected to our health. Recent studies have shown that these microbial communities are implicated in various diseases and that the molecules they produce could be drivers of many pathogenic processes including inflammation. However, much remains to be discovered about…
-
News
19 PhD positions in immunology and chronic inflammation – Apply now!
Learn moreIn the framework of the NextImmune2 Doctoral Training Unit, the University of Luxembourg and the Luxembourg Institute of Health (LIH) are recruiting 19 PhD students to work on research projects focusing on next generation immunoscience.
-
News
Surprising Connection between Immune Balance, Ageing and Parkinson’s
Learn moreLuxembourg Institute of Health (LIH) experts together with collaborators from the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg have begun to unravel the complex links between a key Parkinson’s disease protein and the functionality of specialised immune cells (T cells) with regulatory suppressive functions during ageing. The findings may provide a…
-
News
International team discovers endogenous anti-inflammatory substance
Learn moreA research team led by Prof. Karsten Hiller of the Braunschweig Integrated Centre of Systems Biology, BRICS, in collaboration with scientists at the Luxembourg Institute of Health (LIH) and the University of Luxembourg has discovered an anti-inflammatory chemical substance that the body naturally produces: mesaconic acid. This molecule could be a candidate for further development…
-
News
Midbrain single-cell sequencing to understand Parkinson’s Disease
Learn moreResearchers from the Luxembourg Centre for Systems Biomedicine (LCSB) at the University of Luxembourg, in collaboration with the Max Planck Institute for Molecular Genetics in Berlin, investigated the different cell types present in the human midbrain to better understand their respective role in Parkinson’s disease. They examined post-mortem samples from people affected by the disease and…
-
News
Paul Wilmes elected Executive Board member of the Section des Sciences
Learn moreOn 9 February, Prof. Paul Wilmes, head of the Systems Ecology group at the Luxembourg Centre for Systems Biomedicine (LCSB) of the University of Luxembourg, was elected as a member of the executive board of the Section des Sciences of the Institut Grand-Ducal.